Ritonavir enables combined therapy with rifampin and saquinavir

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1586-

  Veldkamp, A I ^a   Hoetelmans, R M W ^a   Beijnen, J H ^a   Mulder, J W ^a   Meenhorst, P L ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; PROTEINASE INHIBITOR; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR;

ARTICLE; CASE REPORT; COMORBIDITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG MIXTURE; DRUG POTENTIATION; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS; VIREMIA;

DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; RITONAVIR; SAQUINAVIR; TUBERCULOSIS;

EID: 0033374893     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313548     Document Type: Article

References (6)

1. 1. Burman WJ, Gallicano K, Peloquin C. Therapeutic implications of drug interactions in the treatment of human immunodeficiencv virus-related tuberculosis. Clin Infect Dis 1999;28:419-29.
2. 2. Gazzard B, Moyle G, on behalf of the BHIVA Guidelines Writing Committee. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998;352:314-6.
3. 3. Moyle G, Gazzard B. Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs 1996;51:701-12.
4. 4. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998;47(RR-20):1-58.
5. 5. Cameron DW, Japour AJ, Xu Y, et al. Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS 1999;13:213-24.
6. 6. Kirk O, Katzenstein TL, Gersoft J, et al. Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial. AIDS 1999;13:F9-16.